Orthobiologics are substances that orthopedic surgeons use to improve the healing of broken bones and injured muscles, tendons, and ligaments. These products are made from substances that are naturally found in the body; and when used in higher concentrations, orthobiologic substances help speed up the healing process. Osteoarthritis (OA) of knee is a common global cause of disability. There is an increase in the number of non-operative treatment options. Orthobiologic therapy has emerged as a novel yet effective modality for early OA. The report covers profiles of key product manufacturers in the market. These include Stryker Corporation, Zimmer Biomet Holdings, Inc., Wright Medical Group, Inc., Integra LifeSciences Holdings Corporation, Arthrex, Inc. (Arthrex), Johnson and Johnson (J&J), Exactec Inc., Medline Industries, Inc., Globus Medical, Inc., and NuVasive Inc.

CHAPTER 1: INTRODUCTION 

CHAPTER 2: EXECUTIVE SUMMARY 

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: ORTHOBIOLOGICS MARKET, BY PRODUCT

CHAPTER 5: ORTHOBIOLOGICS MARKET, BY APPLICATION

CHAPTER 6: ORTHOBIOLOGICS MARKET, BY TYPE

CHAPTER 7: ORTHOBIOLOGICS MARKET, BY END USER

CHAPTER 8: GLOBAL ORTHOBIOLOGICS MARKET, BY REGION

CHAPTER 9: COMPANY PROFILES